Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where George B. Foscolos is active.

Publication


Featured researches published by George B. Foscolos.


Bioorganic & Medicinal Chemistry Letters | 2001

Novel 3-(2-adamantyl)pyrrolidines with potent activity against influenza A virus-identification of aminoadamantane derivatives bearing two pharmacophoric amine groups.

George Stamatiou; Antonios Kolocouris; Nicolas Kolocouris; George Fytas; George B. Foscolos; Johan Neyts; Erik De Clercq

The 3-(2-adamantyl)pyrrolidines 8a-g, 14 were synthesized and evaluated for activity against influenza A virus. The parent N-H compound 14 was several times more active than amantadine against H(2)N(2) and H(3)N(2) influenza A virus. The combined use of NMR spectroscopy and computational chemistry showed that the conformation around the pyrrolidine-adamantyl carbon-carbon bond is trans and the pyrrolidine heterocycle has an envelope conformation with C-2 out of the plane of the other ring atoms. N-Dialkylaminoethyl substitution of compound 14 resulted in the potent diamine analogues 8e,f,g. Interestingly, their lactam amine precursors were also active. Compounds 8e,f,g are the first adamantane derivatives, bearing two amine groups, reported to be active against influenza A virus.


Bioorganic & Medicinal Chemistry Letters | 2002

New 2-(1-adamantylcarbonyl)pyridine and 1-acetyladamantane thiosemicarbazones-thiocarbonohydrazones: Cell growth inhibitory, antiviral and antimicrobial activity evaluation

Antonios Kolocouris; Kostas Dimas; Christophe Pannecouque; Myriam Witvrouw; George B. Foscolos; George Stamatiou; George Fytas; Grigoris Zoidis; Nicolas Kolocouris; Graciela Andrei; Robert Snoeck; Erik De Clercq

The new thiosemicarbazones and thiocarbonohydrazones derived from 2-(1-adamantylcarbonyl)pyridine and 1-acetyladamantane were synthesized and evaluated for their inhibitory effect on tumor cell proliferation and their antiviral and antimicrobial activity. Thiosemicarbazone inhibited tumor cell proliferation (GI50s range: 2.4-100 microM and mean GI50 43.9 microM against various human leukemic cell lines) while thiosemicarbazone and thiocarbonohydrazone 5d exhibited significant inhibition of tumor cell proliferation (GI50s range 2.3-23.6 microM and mean GI50 7.2 microM for and GI50s range 2.4-32.4 microM and mean GI50 12.8microM for ). These GI50 values are comparable to that of 2-acetylpyridine thiosemicarbazone an important lead in TSCs family. The compounds did not afford specific activity against any of the viruses tested when examined at non-toxic concentrations. A weak activity was found for thiocarbonohydrazones against Gram-(+) bacteria (MIC(50) 117.3 and 133 microM, respectively). Using a combination of molecular mechanics calculations and NOE spectroscopy it was shown that the parent compounds and have opposite configuration around C=N bond. Whether this difference in structure can be correlated with the biological activity will be investigated in future studies.


Antiviral Chemistry & Chemotherapy | 2003

Are the 2-isomers of the drug rimantadine active anti-influenza A agents?

Grigoris Zoidis; Nicolas Kolocouris; George B. Foscolos; Antonios Kolocouris; George Fytas; P Karayannis; Elizaveta Padalko; Johan Neyts; Erik De Clercq

There is a lack of information in the medical chemistry literature concerning the anti-influenza A activity of the drug rimantadines 2-isomer (2-rimantadine). We now present results showing that, although 2-adamantanamine (2-amantadine) 3 is only moderately active, some 2-rimantadine analogues are effective anti-influenza A virus agents in vitro. The 2-rimantadine analogues and their spirocyclobutane and spirocyclopentane congeners were synthesized through interesting routes. The 2-rimantadine analogues were 2–4 times more potent than rimantadine 2 against influenza virus A H2N2 strain; their spirocyclobutane congeners proved equally active to rimanta-dine 2. Two compounds exhibited a similar activity and one of the compounds was was fourfold more potent than rimantadine 2 against H3N2 strain.


Bioorganic & Medicinal Chemistry Letters | 1999

Synthesis of 2-(2-adamantyl)piperidines and structure anti-influenza virus A activity relationship study using a combination of NMR spectroscopy and molecular modeling.

Antonios Kolocouris; Dimitrios Tataridis; George Fytas; Thomas Mavromoustakos; George B. Foscolos; Nicolas Kolocouris; Erik De Clercq

The 2-(2-adamantyl)piperidines 13 and 15a-c were synthesized and evaluated for anti-influenza virus A and B activity. The parent N-H compound 13 was 3-4 times more active than amantadine and rimantadine against H2N2 influenza A. N-alkylation of 13 resulted in derivatives 15a-c that were devoid of biological activity. This dramatic reduction in biological activity may be attributed to the different conformational properties between N-H and N-alkyl piperidines, as deduced from the combination of computational chemistry and NMR spectroscopy.


Bioorganic & Medicinal Chemistry | 2012

Synthesis, σ1, σ2-receptors binding affinity and antiproliferative action of new C1-substituted adamantanes

Stefanos Riganas; Ioannis Papanastasiou; George B. Foscolos; Andrew Tsotinis; Jean-Jacques Bourguignon; Guillaume Serin; Jean-François Mirjolet; Kostas Dimas; Vassilios N. Kourafalos; Andreas Eleutheriades; Vassilios I. Moutsos; Humaira Khan; Stavroula Georgakopoulou; Angeliki Zaniou; Margarita Prassa; Maria Theodoropoulou; Stavroula Pondiki; Alexandre Vamvakides

The synthesis of N-{4-[a-(1-adamantyl)benzyl]phenyl}piperazines 2a-e is described. The in vitro antiproliferative activity of most compounds against main cancer cell lines is significant. The σ(1), σ(2)-receptors and sodium channels binding affinity of compounds 2 were investigated. One of the most active analogs, 2a, had an interesting in vivo anticancer profile against the BxPC-3 and Mia-Paca-2 pancreas cancer cell lines with caspase-3 activation, which was associated with an anagelsic activity against the neuropathic pain.


Bioorganic & Medicinal Chemistry Letters | 1997

Synthesis and anti-HIV activity of some new aminoadamantane heterocycles

George Fytas; George Stamatiou; George B. Foscolos; Antonios Kolocouris; Nicolas Kolocouris; Myriam Witvrouw; Christophe Pannecouque; E. De Clercq

A new class of aminoadamantane heterocycles has been synthesized and examined for anti-HIV activity. Three compounds proved to be active against the replication of HIV-1 in MT-4 cells with an EC50 ranging from 3.6 to 75.2 μM. No activity was noted with any of the compounds against HIV-2.


Journal of Medicinal Chemistry | 2012

New Adamantane Phenylalkylamines with σ-Receptor Binding Affinity and Anticancer Activity, Associated with Putative Antagonism of Neuropathic Pain

Stefanos Riganas; Ioannis Papanastasiou; George B. Foscolos; Andrew Tsotinis; Guillaume Serin; Jean-François Mirjolet; Kostas Dimas; Vassilios N. Kourafalos; Andreas Eleutheriades; Vassilios I. Moutsos; Humaira Khan; Stavroula Georgakopoulou; Angeliki Zaniou; Margarita Prassa; Maria Theodoropoulou; Athanasios Mantelas; Stavroula Pondiki; Alexandre Vamvakides

The synthesis of the adamantane phenylalkylamines 2a-d, 3a-c, and 4a-e is described. These compounds exhibited significant antiproliferative activity, in vitro, against eight cancer cell lines tested. The σ(1), σ(2), and sodium channel binding affinities of compounds 2a, 3a, 4a, and 4c-e were investigated. The most interesting analogue, 4a, exhibited significant in vivo anticancer profile on pancreas, prostate, leukemia, and ovarian cancer cell line xenografts together with apoptosis and caspase-3 activation. Inhibition of the cancer cells cycle at the sub-G1 level was also obtained with 4a. Finally, encouraging results were observed with 4a in vivo on mice, suggesting putative antimetastatic and analgesic activities of this compound.


Medicinal Chemistry | 2012

New Adamantane Derivatives with Sigma Affinity and Antiproliferative Activity

Stefanos Riganas; Ioannis Papanastasiou; George B. Foscolos; Andrew Tsotinis; Kostas Dimas; Vassilios N. Kourafalos; Andreas Eleutheriades; Vassilios I. Moutsos; Humaira Khan; Prassa Margarita; Stavroula Georgakopoulou; Angeliki Zaniou; Maria Theodoropoulou; Athanasios Mantelas; Stavroula Pondiki; Alexandre Vamvakides

The synthesis of 4-(1-adamantyl)-4,4-diarylbutylamines 1, 5-(1-adamantyl)-5,5-diarylpentylamines 2 and 6-(1-adamantyl)-6,6-diarylhexylamines 3 is described and the σ1, σ2-receptors and sodium channels binding affinity of compounds 1 were investigated. The in vitro activity of compounds 1, 2 and 3 against main cancer cell lines is significant. One of the most active analogs, 1a, had an interesting in vivo anticancer profile against the ovarian cancer cell line IGROV-1, which was associated with an anagelsic activity against the neuropathic pain induced by the main anticancer drugs.


MedChemComm | 2013

Synthesis and trypanocidal action of new adamantane substituted imidazolines

Ana Koperniku; Ioannis Papanastasiou; George B. Foscolos; Andrew Tsotinis; Martin C. Taylor; John M. Kelly

Introduction of the hydrophobic substituents cyclopentyl, cyclohexyl and phenyl into adamantane imidazolines was accomplished with the synthesis of compounds 4. Members of this series were found to display a range of activities against bloodstream forms of Trypanosoma brucei.


Heterocycles | 2008

Conformationally constrained adamantaneoxazolines of pharmacological interest

Ioannis Papanastasiou; George B. Foscolos; Andrew Tsotinis; Judit Oláh; Judit Ovádi; S. Radhika Prathalingam; John M. Kelly

New conformationally constrained adamantane 2-oxazoline building blocks 1-4 were synthesized and their antimicrotubule and anti trypanosomal potency was investigated. Although most of the new compounds affect tubulin polymerization, this does not make a major contribution to trypanocidal activity.

Collaboration


Dive into the George B. Foscolos's collaboration.

Top Co-Authors

Avatar

George Fytas

National and Kapodistrian University of Athens

View shared research outputs
Top Co-Authors

Avatar

Nicolas Kolocouris

National and Kapodistrian University of Athens

View shared research outputs
Top Co-Authors

Avatar

Antonios Kolocouris

National and Kapodistrian University of Athens

View shared research outputs
Top Co-Authors

Avatar

Andrew Tsotinis

National and Kapodistrian University of Athens

View shared research outputs
Top Co-Authors

Avatar

Ioannis Papanastasiou

National and Kapodistrian University of Athens

View shared research outputs
Top Co-Authors

Avatar

Erik De Clercq

Rega Institute for Medical Research

View shared research outputs
Top Co-Authors

Avatar

Johan Neyts

Academy of Sciences of the Czech Republic

View shared research outputs
Top Co-Authors

Avatar

Alexandre Vamvakides

National and Kapodistrian University of Athens

View shared research outputs
Top Co-Authors

Avatar

George Stamatiou

National and Kapodistrian University of Athens

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge